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Abstract
Type 2 Diabetes mellitus, as one of the major universal public health disorders 
wide spread, requires patients’ lifestyle modulation which would be conducive 
in dominating blood glucose. The aim of the study was to evaluate the effect 
of lifestyle modification on glycemic control of type 2 diabetic patients at Suez 
Canal University Hospitals at Ismailia city. A quasi-experimental design made up 
of a control group and a study group with pre- and post-test administration was 
applied. This study was carried out at the Family Medicine Outpatient Clinic and 
the Diabetic Outpatient Clinic of Suez Canal University Hospitals at Ismailia city 
in Egypt. 92 type 2 diabetic patients were included in this study. The Diabetes 
Knowledge Questionnaire; Health promoting lifestyle profile II Scale; and Physical 
assessment sheet were used for data collection in the two groups. After implement-
ing of the program, those patients who received lifestyle modification intervention 
achieved better total score of knowledge & knowledge related practice about DM, 
health promoting lifestyle domains values and glycated hemoglobin, compared 
with the control group. Factors related to lower glycated hemoglobin in the present 
study were lower fasting blood sugar level and increasing physical activity. Overall, 
lifestyle modification program has a positive influence on blood glucose control of 
patients with type 2 diabetes mellitus. Therefore, it is recommended to that lifestyle 
modification interventions should be integral part of the curative management of 
type 2 diabetic patients, and further study in other places to investigate the effect of 
lifestyle modification on glycemic control of those patients.
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1. Introduction
Diabetes Mellitus (DM) is one of the widespread and universal health problems 
that affect many people worldwide. It is defined as a metabolic disorder caused by 
different factors, which is characterized by hyperglycemia (elevated blood glucose 
level) and is usually associated with carbohydrate, fat and protein metabolism 
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abnormalities [1]. There are two main types of DM: Type 1diabetes mellitus 
(T1DM) and Type 2 diabetes mellitus (T2DM). T2DM is the commonest form of 
diabetes, constituting nearly 90% of the diabetic patients in any country [2].
Type 2 diabetes mellitus is a heterogeneous and progressive illness, with an 
underlying mechanism ranging from predominantly insulin resistance with relative 
insulin deficiency, to predominantly an insulin secretory defect with lesser degrees 
of insulin resistance. The spread of T2DM is increasing all over the world, probably 
due to the expectations of population’s long life, a sedentary lifestyle and above 
all, the increasing rates of obesity. There are two sub-divisions of T2DM. The “Not 
Insulin Requiring” diabetes, managed by lifestyle measures alone and sometimes 
oral drugs, and the “Insulin requiring for diabetes control”, where insulin is required 
to control, rather than survival [3].
A recent study proved that the uncontrolled diabetes, particularly elevated 
blood sugar over a prolonged period of time could lead to a number of short and 
long-term health complications. Such complications were divided traditionally into 
two main subtypes: the diabetes specific micro-vascular complications of retinopa-
thy, nephropathy, and neuropathy which were caused by injuries to the small blood 
vessels; and the thrombotic macro-vascular complications of myocardial infraction, 
hypertension, and peripheral arterial disease which were presented due to arterial 
damage [4].
Many chronic diseases, as proved by recent studies, are associated with poor 
lifestyle and unwise human conduct. Lifestyle is an individual’s typical way of life 
which includes activities and attitudes that influence man’s health, whether healthy 
or unhealthy. A healthy lifestyle often results in better health and happiness. In con-
trast, an unhealthy lifestyle may cause illness and morbidity. Lifestyle related risk 
factors are associated with the development and progression of T2DM. These risk 
factors such as sedentary lifestyle, smoking, alcohol consumption, dietary choices 
and overweight are modifiable. The cornerstone of DM management includes 
appropriate lifestyle choices supported by regular medication and blood glucose 
self-monitoring, where necessary [5, 6].
The core of Type 2 diabetes mellitus treatment depends mainly on physical 
activity and nutrition therapy. The recent studies have proved the benefits of physi-
cal activity on individuals who maintain a physically active lifestyle and therefore, 
they are less likely to develop insulin resistance, impaired glucose tolerance, or 
T2DM. The effects of exercise training on glycemic control and related physiologi-
cal parameters have also been extensively studied in type 2 diabetic patients. On 
the same line, healthy nutrition is the basis for the treatment of T2DM. It positively 
maintains blood glucose to be within normal limits and effectively minimizes the 
complications of the T2DM and weight loss is also an important goal because it 
improves glycemic control [7, 8].
The community health nurse had an effective role in patient education about all 
newly lifestyle modification for T2DM. No matter that encouraging and supporting 
lifestyle modifications could help in enabling type 2 diabetic patients to feel more 
satisfied in controlling of their disease. Pender’s health promotion model (HPM) is 
one of the widely used models to plan for changing unhealthy behaviors and promote 
general hygiene. Pender’s model was developed after the health belief model, to assist 
nurses in understanding the major determinants of health behaviors as a basis for 
behavioral counseling to promote healthy lifestyles. According to Pender’s model, 
health promotion is a dynamic and positive process that encompasses conducts 
supporting a healthy lifestyle, including physical activity, dieting, spiritual growth, 
interpersonal relationships, health responsibility, and stress management. In nutshell, 
a health-promoting lifestyle is a multi-dimensional pattern of voluntary behaviors 
needed for promoting one’s health conditions, self- growth, and perfection [9].
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Moreover, a great importance should be paid for the patients’ regular follow-up 
with the health care provider so as to avert any long-term complications. In diabetes 
Mellitus care, lifestyle modification can prevent or delay the complications and also 
decrease the need for medication. Because of the alarming and danger threaten DM 
statistics, the sacred role of nurses in assisting patients to control associated mor-
bidity and mortality is becoming increasingly significant. Nurses, who are always 
on the front line, can screen patients for early diabetes identification, recognize and 
initiate corrective measures for inadequate treatment regimens, help patients set 
and achieve therapeutic goals and assess diabetes-related complications as soon as 
they arise [10]. DM, as a chronic disease, often has a relapsing and remitting course 
with substantial impact on function and quality of life (QOL). For chronic illnesses 




Diabetes Mellitus (DM) is a complex, chronic disease that caused by inherited 
and/or acquired deficiency in production of insulin by the pancreas or by the 
ineffectiveness of the insulin produced; both require continuous medical care 
with multifactor risk-reduction strategies beyond glycemic control. It is defined 
as a metabolic disorder caused by different factors and is characterized by hyper-
glycemia (elevated level of blood glucose) with disturbances in carbohydrate, fat 
and protein metabolism. The chronic hyperglycemia is associated with long-term 
damage, dysfunction and degeneration/deterioration of various organs, particularly 
eyes, kidney, nerves, heart and blood vessels [8, 11].
1.1.2 Etiologic classification of DM
This classification includes four types:(1) Type 1 diabetes mellitus (T1DM), (2) 
Type 2 diabetes mellitus (T2DM), (3) Other specific forms of diabetes: Genetic 
defects of beta cell function; Genetic defects of insulin function; exocrine pancre-
atic diseases; Endocrinopathies; drugs and chemicals; infections; rare immunologic 
forms of diabetes; other genetic syndromes associated with diabetes; Latent auto-
immune diabetes in adults (LADA); Maturity-onset diabetes of the young (MODY)
and (4) Gestational diabetes mellitus (GDM) [8].
The majority of cases of diabetes can be broadly classified into 2categories: 
T1DM– autoimmune which is primarily a result of pancreatic beta cell destruc-
tion with consequent insulin deficiency, which is prone to ketoacidos is. This form 
includes cases due to an autoimmune process and those for which the etiology of 
beta cell destruction is unknown; T2DM – may range from predominant insulin 
resistance with relative insulin deficiency to a predominant secretory defect with 
insulin resistance. Ketosis is not as common. GDM refers to glucose intolerance with 
onset or first recognition during pregnancy. Other specific types include a wide 
variety of relatively uncommon conditions, primarily specific genetically defined 
forms of diabetes or diabetes associated with other diseases or drug use [12].
1.1.3 Latent autoimmune diabetes in adults
Latent autoimmune diabetes in adults (LADA) is a late manifesting autoimmune 
form of diabetes in adults, most commonly diagnosed in patients above35years of 
age, characterized by clinical insulin independence in the first months after the 
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diagnosis, with the presence of serum antibodies against glutamic acid decarbox-
ylase (anti-GAD65) and/or other anti-islet antibodies and a low serum peptide C 
level. LADA is a form of T1DM with slowly progressive autoimmune-mediated 
destruction of beta cells. This diabetes subtype is present in 5–10% of subjects with 
diabetes diagnosed after 35 years of age and categorized asT2DM. Clinical mani-
festations of LADA do not always allow a definite diagnosis, presenting diagnostic 
challenges when differentiating with T2DM. A definite diagnosis of LADA requires 
identification of auto-antibodies typical for T1DM, mostly antiGAD65, and/or a low 
serum peptide C level [13].
1.1.4 Monogenic diabetes
Monogenic diabetes amounts to 1–2% of all diabetes cases. It is caused by single 
gene mutations. Most forms are associated with a defect of insulin secretion, and 
the most common ones are maturity-onset diabetes of the young (MODY), mito-
chondrial diabetes, and neonatal diabetes. Considering the monogenic forms in the 
differential diagnosis of diabetes may contribute to treatment optimization and 
proper evaluation of prognosis in the patient and his family members. A definite 
diagnosis of monogenic diabetes is a result of genetic testing. The most common 
form of MODY is associated with HNF1A and glucokinase gene mutations [13].
Typical clinical presentation of MODY due to an HNF1Agene mutation includes: 
(1) Early onset of diabetes (typically before 25 years of age; (2) No insulin depen-
dence and keto acidosis, low insulin requirement, detectable peptide C levels 
despite the disease being present for several years or even longer; (3) Diabetic 
family history over at least 2 generations, with early-onset diabetes in at least two 
family members. OGTT performed at an early stage of diabetes usually shows 
high postprandial glucose level elevation with often normal fasting blood glucose; 
(4) Absence of auto antibodies typical for T1DM; and (5) Glycosuria higher than 
expected based on blood glucose levels [13].
1.2 Type 2 diabetes mellitus
1.2.1 Type 2 diabetes mellitus (T2DM)
It is universally known that Type 2 diabetes mellitus is considered a modern-day 
epidemic of epic proportions, affecting all classes of the society. The prevalence 
is becoming alarmingly high among younger age groups. Global prevalence of 
diabetes mellitus is about 9%. The prevalence of diabetes is expected to double by 
2030 from 8.3 to 17.6% globally, excluding the high numbers of undiagnosed cases 
estimated as 175 million. Approximately 1.9% of the global disability adjusted life 
years (DALY) is attributed to diabetes. The International Diabetes Federation (IDF) 
estimates that 450 million people are living with diabetes, with 5.1million dying 
from it annually worldwide. T2DM is the greatest contributor to the burden of 
diabetes globally accounting for up to 90% of people with diabetes worldwide [14].
T2DM is a chronic and progressive medical condition which results from two 
major metabolic dysfunctions: insulin resistance and a relative insulin deficiency. 
Insulin resistance in which clinical signs may include: acanthosisnigricans–charac-
terized by hyper pigmentation (darkening of skin pigment) especially in the neck 
and axillae; skin tags – benign (non-cancerous) skin growths on the body or face; 
central obesity – defined by a high waist-to-hip ratio, waist-to-thigh ratio and waist 
circumference; menstrual irregularities; and hirsutism– excess facial and body hair, 
especially on women. A relative insulin deficiency in which chronic hyperglycemia 
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with multiple disturbances in carbohydrate, protein and fat metabolism develops 
when a person’s beta cell function is no longer sufficient to meet his/her insulin 
requirement [15].
1.3 Risk factors of T2DM
Several factors contribute to the high incidence of DM, such as population growth 
rate, ageing population, age structures, urbanization, unhealthy diet habits, obesity, 
sedentary lifestyles, lack of physical activities, failure to access to healthcare facilities 
both in rural and urban areas in addition to the economic and health transition of the 
country. Moreover, the increased case of DM is also triggered by the positive family 
history of the disease [16]. The literature reveals three interrelated spheres of risk 
factors that contribute to the development of T2DM: (1) genetics, (2) environment or 
lifestyle, and (3) metabolic abnormalities. It is imperative to implement appropriate 
interventions for the prevention and treatment of T2DM among adult patients, where 
there is an understanding of the risk factors predisposing adults to this disease [17].
1.3.1 Genetic factors
Although research has not clarified a single gene that is alone responsible for 
the development of T2DM, there are many findings in literature that support the 
genetic hypothesis. Higher concordance rates are found among identical (96%) 
than dizygotic twins in some but not all twin studies which have been a compelling 
evidence of a significant genetic component in T2DM. Moreover, 40% of first-
degree relatives of T2DM patients may develop diabetes, whereas the incident rate is 
only 6% in the general population [5].
• Environmental or lifestyle factors:
There are a wide range of lifestyle factors which are of great importance to the 
development of T2DM disease, such as smoking, alcohol consumption, physi-
cal inactivity, obesity, obstructive sleep apnea, unhealthy diet (dietary fiber (a 
low-fiber diet with a high glycemic index), dietary fat (total and saturated fat 
intake) and frequent consumption of processed meat [5].
• Metabolic abnormalities or changes:
A recent study proved that resistance to insulin was the underlying abnor-
mality in most people who develop T2DM. Such resistance resulted from an 
interaction between both genetic and environmental factors. Those factors 
were associated with the development of insulin resistance. The initial reac-
tion of the beta cells was to increase output of insulin in order to overcome the 
insulin resistance and to maintain normal blood glucose levels. Unless insulin 
resistance was reversed, hyper secretion of insulin was insufficient to maintain 
normoglycemia indefinitely and progression to the states of impaired glucose 
metabolism (impaired fasting glucose (IFG), impaired glucose tolerance (IGT) 
and eventually T2DM) [18].
1.4 Pathophysiology of T2DM
The main pathophysiological cause of T2DM is the failure of pancreatic beta 
cells which leads to inadequate secretion of insulin and increased insulin resistance 
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which refers to decreased tissue (especially the liver, adipose tissues and muscle) 
sensitivity to insulin. Normally, insulin binds to special receptors on cell surfaces 
and initiates a series of reactions involved in glucose metabolism. In T2DM; 
intracellular reactions are diminished, making insulin less effective at stimulating 
glucose uptake by the liver. Physical inactivity and obesity lead to insulin resistance, 
increased production of glucose by the liver and decreased glucose uptake in skel-
etal muscles. In order to compensate beta cells, increase insulin secretion, but the 
progressive failure of beta cells leads to hyperglycemia and finally T2DM [19, 20].
The inappropriately increased alpha-cell function and consequent hypergluca-
gonemia, in addition to insulin resistance and beta cell dysfunction, they all have 
long contributed to hyperglycemia in diabetic patients, by stimulating hepatic 
glucose production. In fasting state, hyperglycemia is directly related to increase 
hepatic glucose production while in postprandial state, hyperglycemia results from 
the combination of insufficient suppression to glucose output and defective insulin 
stimulation of glucose disposal in target tissues, mainly skeletal muscles. Anti-
hyperglycemic agents are directed to one or more of the pathophysiological defects 
of T2DM; they modify physiological processes related to appetite, nutrient absorp-
tion or excretion [21, 22].
1.5 Clinical manifestation of T2DM
It is almost traditionally known that classic symptoms of diabetes are polyuria 
(the need to urinate frequently), polydipsia (increased thirst & fluid intake), poly-
phagia (increased appetite) and weight loss and the symptoms that may provide 
cause for testing T2DM include increased thirst or urination, numbing of extremi-
ties, impotence, blurred vision and fatigue [23]. Other symptoms that are com-
monly present at diagnosis include; a history of blurred vision, itchiness, peripheral 
neuropathy, recurrent vaginal infections, poor healing skin wounds and fatigue. 
Patients with T2DM may rarely present with non-ketonic hyperosmolar coma, a 
condition of very high blood sugar associated with a decreased level of conscious-
ness and low blood pressure. Many people however have no symptoms during the 
first few years which are diagnosed on routine testing [24].
1.6 Diagnosis of T2DM
The diagnostic criteria for diabetes mellitus are at least one of the following: 
[1] Glycated hemoglobin test (HbA1c) ≥ 6.5%. That test should be performed in a 
laboratory using the National Glycohemoglobin Standardization Program (NGSP) 
method which was certified by the NGSP standardized to the Diabetes Control and 
Complications Trial (DCCT) assay; [2] The Fasting Plasma Glucose Test (FPG) ≥ 
126 mg/dl. Fasting is defined as no caloric intake for at least 8h; [3] 2-hour plasma 
glucose ≥ 200 mg/dl during an Oral Glucose Tolerance Test (OGTT). This test 
should be performed as described by the WHO, using a glucose load containing the 
equivalent of 75 g, anhydrous glucose dissolved in water; or [4]. In a patient with 
classic symptoms of hyperglycemia (polyuria, polydipsia, weight loss) or hyper-
glycemic crisis (Diabetic ketoacidosis (DKA), Hyperglycemic Hyperosmolar State 
(HHS)), a random plasma glucose ≥200mg/dL (11.1mmol/L). In the absence of 
unequivocal hyperglycemia, results should be confirmed by repeat testing [25].
1.7 Complications of T2DM
T2DM is considered as one of the most leading causes of premature morbidity 
and mortality worldwide as a result of the long-term micro vascular and macro 
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vascular complications associated with this disease. For instance, diabetic retinopa-
thy is the most leading cause of blindness among adults aged 20-74 years; diabetic 
nephropathy, which affects approximately 40% of type 2 diabetic patients, is the 
leading cause of chronic kidney disease in patients starting replacement therapy; 
and diabetic neuropathy, which affects up to 50% of individuals with diabetes, 
increases the risk of foot ulcers and limb amputation [26].
In fact, more than 80% of non-traumatic limb amputations follow a foot ulcer 
or injury, and the risk of amputation in individuals with diabetes is up to 25 times 
greater compared with patients without diabetes. Although micro vascular com-
plications increase morbidity and lead to premature mortality, the major cause of 
death in individuals with diabetes is cardiovascular disease (CVD), which in turn 
accounts for approximately 65% of all diabetes-related deaths. For example, tran-
sient ischemic attacks are 2-6 times more common in patients with T2DM, while the 
risk of developing heart failure is a startling 2- to 8-fold higher [26].
The sudden development of short-term complications, such as hyperglyce-
mic crisis (DKA, HHS and severe hypoglycemia) that can lead to coma and, if 
untreated, death, are a daily threat to the many people worldwide with diabetes 
who have major difficulty in accessing essential treatment supplies (including 
insulin) [27].
Recent studies have shed the light on "hypoglycemia" (blood glucose < 3.9 
mmol/L or 70 mg/dL) as a common unwanted effect in people treated with insulin 
and occurs when there is an imbalance in insulin dose, food consumed and activity. 
Usually the condition is manageable, but occasionally, it can be severe or even life 
threatening, particularly if the patient fails to recognize the symptoms, especially 
while continuing to take insulin or other hypoglycemic drugs. The signs of hypo-
glycemia can vary from person to person and may occur suddenly such as: hunger, 
perspiration, rapid heartbeat, weakness, feeling sleepy, feeling drunk, difficulty 
speaking, trembling, dizziness, confusion, and anxiety [28, 29].
DKA results from absolute insulin insufficiency, leading to metabolic acidosis 
(pH <7.3), hyperglycemia (blood glucose >11 mmol/L). DKA may also be pres-
ent in up to 25% of young people presenting with T2DM. DKA should be treated 
as a medical emergency by an experienced medical team [30]. Hyperglycemic 
Hyperosmolar Non ketonic Syndrome (HHNS) usually occurs with T2DM and can 
occur with T1DM. It is often triggered by a serious infection, another severe illness, 
or by medications that lower glucose tolerance or increase fluid loss (especially in 
people who are not drinking enough fluids). Symptoms of HHNS include; high 
blood sugar levels, dry mouth, extreme thirst, dry skin and high fever. HHNS leads 
to loss of consciousness, seizures, coma and death [31].
No doubt, early detection and good glycemic control can slow the progression 
of the acute and chronic complications of DM, which cause significant mortality 
and morbidity in both developing and developed countries. Such chronic com-
plications of DM if once developed are irreversible except by early detection and 
 management [4].
1.8 Management of T2DM
Both patients and health care professionals are partners in managing T2DM, in 
which the health professionals support the patients in self-managing their disease. 
Management of every patient should start with a detailed evaluation of the initial 
diagnosis including diabetes complications and its risk factors. This, of course, 
provides basis for continuing treatment plan, treatment administration, monitor-
ing, and review [32]. The main goals of treatment of DM are to reduce complica-
tions through control of glycaemia, blood pressure, macro vascular (i.e., coronary, 
Psychology and Pathophysiological Outcomes of Eating
8
cerebrovascular, peripheral vascular), control of lipids, hypertension and smoking 
cessation. Metabolic and neurological complications can be reduced through 
control of glycaemia [33].
The treatment of hyperglycemia should start with the establishment of a target 
HbA1c that, in most cases, will be ≤ 7.0%, as this has been shown to reduce long-
term microvascular complications in newly diagnosed patients with T2DM. HbA1c 
targets may be higher (up to 8.5%) if the benefits of intensive glycemic control are 
unlikely to outweigh the risks and burden, such as in individuals with limited life 
expectancy, high risk of hypoglycemia, multimorbidity, or based on the values and 
preferences of the person with diabetes. It should be emphasized to people with 
T2DM that reductions in HbA1c levels are associated with better outcomes even if 
recommended glycemic targets cannot be reached, and inability to achieve HbA1c 
target should not be considered a treatment failure [34].
If the level of HbA1c at diagnosis is less than 1.5% above target and the person 
with T2DM, lacks metabolic decompensate and/or symptoms of hyperglycemia, 
the first step of treatment should be healthy lifestyle conduct. If healthy behavior 
interventions are insufficient to achieve target HbA1c levels within 3 months, they 
should be combined with oral antihyperglycemic medications (Table 1) [35].
In the face of significant hyperglycemia (i.e., HbA1c >1.5% above target), 
pharmacotherapy is usually required at diagnosis concurrent with healthy behav-
ior interventions. People who have evidence of metabolic decompensation (e.g., 
marked hyperglycemia, ketosis or unintentional weight loss) and/or symptomatic 
hyperglycemia should be started immediately on insulin, regardless of HbA1c level. 
Insulin may later be tapered or discontinued once stability is achieved [34].
2. Glycemic control
Glycemic control is extremely fundamental to the management of T2DM. Diabetes 
management aims to delay the onset of disease complications, and to hinder its progres-
sion, mostly by improving glycemic control and controlling the risk of cardiovascular 
disease. Previous studies have provided evidence of the power of good glycemic control 
to restrict the micro-vascular and macro-vascular complications of diabetes [36].
2.1 Assessment of glycemic control
Glycemic control is a very important instrument that prevents or delays the 
complications associated with DM, such as peripheral vascular disease, vision loss, 
S.no Category Examples
1 Sulfonylureas First generation Acetohexamide,Chlorpropamide, Tolbutamide, Tolzamide




5 Alpha-glucosidase Inhibitors Acorbose, Miglitol
6 Glucagon like peptide-1-agonist Exenatide, Liraglutide
7 Amylinomimetics Pramlintide acetate
Table 1. 
Oral antihyperglycemic agents for T2DM [35].
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and renal failure. There are two primary techniques available for both health pro-
viders and patients to assess effectiveness of management plan on glycemic control: 
patient self-monitoring of blood glucose (SMBG) and HbA1c [37].
2.1.1 Self-monitoring of blood glucose (SMBG)
The first primary technique to assess the effectiveness of glycemic control plan 
for diabetic patients is the self-monitoring of blood glucose since most people with 
diabetes get benefit from monitoring of blood glucose for a various reasons. SMBG 
is the optimal way to confirm and appropriately treat hypoglycemia. It can provide 
feedback on the results of healthy behavior interventions and antihyperglycemic 
pharmacological treatments. It can increase patient’s empowerment and adherence 
to treatment. It can also provide information to both the diabetic patient and the 
diabetes health-care team to facilitate longer-term treatment modifications and 
titrations as well as shorter-term treatment decisions, such as insulin dosing for 
people with T1DM or T2DM. Finally, in situations where HbA1c does not accurately 
reflect glycaemia, monitoring of blood glucose is necessary to monitor glycaemia 
adequately [38].
For people with T2DM treated with healthy behavior interventions, with or 
without non-insulin antihyperglycemic agents, the effectiveness and frequency of 
monitoring of blood glucose in improving glycemic control is less clear. The evi-
dence is less certain in people with T2DM treated with insulin, although the above 
principle likely applies. In a large, non-randomized study of individuals with stable 
T2DM using insulin, testing at least 3 times a day was associated with improved 
glycemic control [38].
2.1.2 Glycated hemoglobin (HbA1c)
Glycated hemoglobin (HbA1c) can be used as a diagnostic test for diabetes 
providing that strict quality assurance tests. An HbA1c of 6.5% is recommended 
as the cut point for diagnosing diabetes. A value of less than 6.5% does not exclude 
diabetes diagnosed using glucose tests. HbA1c is a reliable estimate of mean plasma 
glucose levels over the previous 8 to 12 weeks. The mean blood glucose level in the 30 
days immediately preceding the blood sampling (days 0 to 30) contributes 50% of 
the result and the prior 90 to 120 days contributes 10%. HbA1c is a valuable indicator 
of treatment effectiveness and should be measured at least every 3 months when 
glycemic targets are not being met and when diabetes therapy is being adjusted or 
changed. It is a measure of long-term blood glucose concentration and is not affected 
by acute changes in glucose levels due to stress or illness. Testing at 6-month intervals 
may be considered in situations where glycemic targets are consistently achieved. 
In some circumstances, such as when significant changes are made to therapy, or 
during pregnancy, it is appropriate to check HbA1c more frequently [38].
An appropriate level of HbA1c is difficult to define exactly; therefore Target 
HbA1c should be defined based on personal assessment of risks and benefits of 
treatment. The factors limiting the benefit of tight control are co-morbidities (e.g., 
end-stage cancer, severe heart failure), advanced diabetes complications (e.g., 
proliferative retinopathy, renal failure), inability to safely carry out treatment regi-
men, and limited life expectancy; or factors that heighten the risk of tight control: 
history of severe hypoglycemia (inability to treat without assistance), hypoglycemia 
unawareness and advanced cardiovascular or cerebrovascular disease, in addition to 
autonomic neuropathy (especially cardiac), comorbidities that impair the detection 
of hypoglycemia (e.g., alteration in mental status, alcoholism, etc…), and/or poor 
social support [39].
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Patients who do not have any of these factors possibly would generally have a 
target HbA1c of ≤ 7%. Patients who do have one or more of these factors should 
have a goal of minimizing symptoms of hyperglycemia and to control glucose as 
well as possible without incurring side effects or excessive treatment burden; while 
an appropriate HbA1c is difficult to define exactly, treatment should be aimed to 
keep the HbA1c under 9% [39].
2.2 Type 2 diabetes mellitus lifestyle modification
Lifestyle modification or modification of unhealthy lifestyle choices such as: 
physical inactivity, unhealthy diet, harmful use of tobacco and/or alcohols can 
reduce the risk of complications and premature death of T2DM, by contributing 
to a better glycemic control. At diagnosis, highly motivated patients with HbA1c 
levels (<7.5%) could be given opportunity to engage in lifestyle modification for 
3-6 months before staring pharmacotherapy. Encouraging and supporting people 
to make the best choices about their health can lead to a real difference to people’s 
quality of life. Some studies have conclusively shown that reducing hyperglycemia 
decreases the onset and progression of microvascular complications and individual-
ized dietary plan, regular physical activity and weight loss, when required, have 
been recognized as key components of diabetes management [22, 40].
The required lifestyle changes in managing DM are influenced by patient’s 
knowledge, attitudes, practices, culture and values. Lack of knowledge about 
diabetes has been identified as one of the barriers to self-management of diabetes. 
Lack of understanding of how to manage diabetes also has a significant impact on 
limited diabetes knowledge in this population. Lifestyle modification counseling or 
education is the key component to achieve good glycemic control, to reduce the risk 
of diabetes complications, improve self-management and enhance the quality of 
life of type 2 diabetic patients including medical nutrition therapy, regular physical 
activity, weight reduction, and diabetes self-management education and support. 
Lifestyle interventions with oral hypoglycemic agents are often effective [8, 41].
2.3 Components of the lifestyle modification program
2.3.1 Medical nutrition therapy (MNT) for T2DM
Type 2 diabetic patients should consult a registered dietician (RD) to know 
about nutrition therapy for managing DM. MNT for type 2 diabetic patients 
encourages meal choices based on the patient’s own needs and preferences, while 
awareness of the importance of dietary control promotes planning of meals and 
adherence to dietary regimen. There are some of the general dietary guidelines to 
follow to help manage diabetes are not to skip meals, to evenly distribute the meals 
throughout the day in small portions and to have a diet low in saturated fat [42, 43].
The goals of MNT include improving control of blood glucose levels, lipid 
profiles, and blood pressure to reduce the risk of cardiovascular disease in patients 
with T2DM through implementing lifestyle changes which reduce intakes of energy, 
saturated and trans fatty acids, cholesterol, and sodium and increase physical 
activity. Achieving these goals requires the dietitian and other professionals to teach 
and otherwise assist type 2 diabetic patients to modify or manage their nutritional 
intake in the light of a variety of individual factors such as: medication, exercise. 
Plasma glucose monitoring can be used to determine whether adjustments to foods 
and meals will be sufficient to achieve glycemic control or if medication(s) needs to 
be combined with MNT. MNT has been shown to reduce glycosylated hemoglobin 
(HbA1c) by 1% to 2% in patients with T2DM [44].
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2.4 Diet composition
2.4.1 Carbohydrates (CHO) in T2DM management
Type 2 diabetic patients are persuaded to keep track of the amount of CHO 
they eat. The amount and the type of CHO ingested usually affects postprandial 
response. The recommended daily allowance (RDA) for CHO (130 g/day) is an 
average minimum requirement but less than 130 g/day of CHO is not recommended 
because the brain and central nervous system have an absolute requirement for 
glucose as an energy source. About 45-60 grams of carbohydrate can be consumed 
at a meal. Perhaps more or less CHO needed at meal depending on how diabetes is 
being managed [37].
Carbohydrate intake should be from sources like: fruits, vegetables, whole 
grains, lentils and legumes, and low-fat dairyproducts. However, carbohydrates 
should not be avoided completely as carbohydrate containing food is also a good 
source of fiber, vitamins and minerals which are extremely essential for the proper 
functioning of the body [45].
2.4.2 Glycemic index(GI)
Glycemic Index concept has best described the type of CHO. Researchers devel-
oped the GI of food to compare the physiologic or postprandial effects of carbohy-
drates (usually 50 g carbohydrate portion) on glucose. Glucose is given a value of 
100; other CHOs are given a number relative to glucose. A ranking system indicates 
how quickly CHO food raises blood glucose15level. The higher the blood glucose 
responses, the higher the GI ranks carbohydrate foods according to their effect on 
blood glucose levels. GI ranges, in general: low GI foods < 55, intermediate GI foods 
55 – 70, and high GI foods > 70. Foods with low glycemic indexes such as: oats, 
barely, lentils, beans, fiber… etc., Substituting high GI foods with lower GI foods at 
mealtime reduces postprandial blood glucose [46]. Detailed lists can be found in the 
International Tables of Glycemic Index and Glycemic Load Values [47].
2.4.3 Dietary fiber
It is scientifically well known that fibers are non-digestible carbohydrates. 
Soluble fibers help to slow down the digestion of starches and absorption of glucose. 
Example: fruit pectin (guava, apples, and plums), oats fiber, and legume fiber 
(beans & lentils). Some studies proved that consuming a high-fiber diet (50 g fiber/
day) improves the postprandial glycemic response, reduces hyperinsulinemia, and 
lipemia in type 2 diabetic patients. Dietary Reference Intakes (DRI) recommended 
consumption of 14 g dietary fiber per 1000 kcal (or 25 g for adult women and 38 
g for adult men) based on epidemiologic studies but usual fiber intake (up to 24 g 
daily) not shown to have beneficial effects on glycaemia. Good sources of fibers are: 
whole grain cereals, fruits, vegetables, beans and peas. Whole grains (contains the 
entire grain seed, bran, germ & endosperm) are not associated with improved gly-
cemic control but may reduce systemic inflammation. The diabetic patient should 
consume at least half of all grains as whole grains [48, 49].
2.4.4 Nutritive and non-nutritive (calorie-free) sweeteners
Nutritive sweeteners contain sucrose and fructose. Sucrose (table sugar), a disac-
charide-containing glucose and sucrose-containing foods have proven not to have a 
significant effect on glycemic levels of diabetic patients and therefore, do not need to 
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be restricted but fat ingested with sucrose (ice cream) will increase calories. Fructose 
produces a lower postprandial glucose response when it replaces sucrose or starch in 
the diet; however, fructose may adversely affect plasma lipids. Therefore, the use of 
added fructose as a sweetener in the diabetic diet is not recommended. It is founded in 
fruits, honey and vegetables. The US Food and Drug Administration (FDA) approved 
non-nutritive sweeteners such as: aspartame and saccharin are safe for diabetic 
patients when consumed within the acceptable daily intake levels established by the 
FDA. Diabetic patients should limit/avoid intake of sugar sweetened beverages to 
reduce risk for weight gain and worsening of cardio metabolic risk profile [37].
2.4.5 Protein in T2DM management
No ideal amount of protein recommended for patients without evidence of 
diabetic kidney disease except (protein intake typically 1-1.5 g/kg body weight) 
so as to optimize glycemic control or to improve one or more CVD risk measures. 
In T2DM: ingested protein increases insulin response without increasing plasma 
glucose concentrations. Therefore: CHO sources high in protein should not be used 
to treat or prevent hypoglycemia. For those with albuminuria and reduced glomeru-
lar filtration rate, dietary protein should be maintained at 0.8g/kg body weight/day. 
Reducing the amount of dietary protein below the recommended daily allowance 
is not advocated because it does not alter glycemic measures, cardiovascular risk 
measures or the rate at which glomerular filtration rate declines. Meals with > 75 
g protein can raise post prandial glucose at 3-5 hours following consumption. The 
effect of protein & fat is additive (high fat increases insulin resistance). Protein 
from fish and chicken may also be included in the diet, however consumption of red 
and processed meat should be avoided [50, 51].
2.4.6 Dietary fat and cholesterol in T2DM management
It is recommended for type 2 diabetic patients to follow the guidelines for the 
recommended intakes of saturated fat dietary cholesterol and trans-fat since the 
type of fatty acids consumed is more important than total amount offal when 
looking at metabolic goals and CVD risk. Monounsaturated fats may improve 
glucose metabolism and lower CVD risk and can be an effective alternative to a diet 
low in total fat but relatively high in CHO. Eating foods rich in Omega-3 fatty acids 
(fatty fish, nuts and seeds) is recommended to prevent or treat CVD (not supple-
ments though). Monounsaturated and polyunsaturated fats are recommended over 
saturated fat. In general, trans-fat should be avoided. In animal & observational 
studies, higher intakes of total dietary fat produce greater insulin resistance. In 
clinical trials saturated & trans-fats have been shown to cause insulin resistance 
whereas mono- & polyunsaturated and omega-3 fatty acids do not have an adverse 
effect. Polyunsaturated fats are as beneficial as monounsaturated fats. Individuals 
with diabetes and Dyslipidemia may be able to modestly reduce total and low-
density lipoprotein (LDL) cholesterol by consuming 1.6-3 g/day of plant stanols 
or sterols typically found in enriched foods such as: corn and soy <300 mg dietary 
cholesterol/day is recommended [50, 51].
2.4.7 Sodium
Generally, diabetic patients are advised to limit their sodium consumption to 
< 2.300 mg/day. Lowering sodium intake (i.e., 1.500 mg/day) could improve blood 
pressure in certain circumstances. However, other studies suggested caution for 
universal sodium restriction to 1.500 mg in diabetic patients [8].
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2.4.8 Micronutrients and herbal supplements in T2DM management
There is no clear evidence that supplementation in diabetic patients without 
deficiencies with vitamins, minerals, herbs or spices can improve diabetes. There 
is insufficient evidence to support the routine use of chromium, magnesium and 
vitamin D to improve glycemic control in people with diabetes. There is insufficient 
evidence to support the use of cinnamon for diabetes treatment. May be safety 
concerns regarding long-term use of antioxidant supplements such as: vitamin E, 
vitamin C and carotene [51].
2.4.9 Meal planning
There is no ideal meal plan that works for everyone with diabetes. Regardless of 
which meal planning method is used, it should be individualized and modified to 
put into practice with less difficulty. Meals and snacks should be distributed that is 
consistent with each individual’s way of life, activity patterns and diabetes medica-
tion at regular meal times. Spacing of meals: MNT as monotherapy: 3 moderate 
meals or 4 smaller meals, snacks based on pt’s schedule and preferences; MNT with 
oral anti-diabetes agents: moderate to small in size, snacks not needed unless risk of 
low BG, and maintain the consistent timing of meals and carbohydrates; and MNT 
with insulin: keep meals moderate to small in size. Avoid skipping meals. Varieties 
of eating patterns (combinations of different foods or food groups) are acceptable. 
Meal planning method ranges from simple guidelines to more complex counting 
methods. A simple diabetes meal planning approach such as: portion control or 
healthful food choices may be better suited to individuals with T2DM identified 
with health and numeric literacy concerns [45, 52].
It is widely acceptable that the healthy nutrition is a basis for T2DM treatment. It 
contributes positively to the maintenance of blood glucose within normal range and 
minimizes the disease complications. A balanced diet consisting of 45–60% energy 
from carbohydrate, 15–20% energy from protein and 20–35% energy from fats is 
encouraged. There is no ideal eating pattern that is expected to benefit all diabetic 
patients, but the total energy intake (and thus portion size) is an important factor 
no matter which eating pattern is chosen [8].
2.5 Physical activity for T2DM
Physical activity and exercise are just as important as nutrition for type 2 dia-
betic patients. Physical activity includes any movement that increases energy use; 
whereas exercise is considered a more specific form of physical activity designed to 
improve physical fitness. Exercise has been shown to have several benefits includ-
ing: improved blood glucose control, reduced cardiovascular risk, increased energy 
as well as burning extra calories and fat to help manage weight and improve wellbe-
ing. Exercise interventions of at least8 weeks also have shown to lower HbA1c in 
those with T2DM [42].
2.6 The basic principles of an effective exercise program
The basic principles of an effective exercise program are its intensity, its dura-
tion, and its exercise frequency. The intensity of exercise should be sufficient to 
cause changes in the cardiorespiratory system and is determined either by the 
physical condition of each patient or by the heart rate. In non-fit patients, the inten-
sity can be set to 50-60% of maximum heart rate or to the intensity that increases 
the resting heart rate by 20 pulses per minute. The duration of the exercise should 
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be 30 minutes in the beginning, starting with 5-10 minutes of warm-up and finish 
always with recovery exercises. The lower frequency recommended is 3 times/week. 
Usually, low intensity and long-duration exercise programs are considered the most 
appropriate and safe for diabetic patients. Finally, the subjective perception of 
fatigue should be continuously assessed throughout the whole exercise session [53].
There are other important parameters that need to be estimated during exercise 
sessions are the levels of blood glucose before and during the exercise, the type 
of food and the time prior to exercise that it was consumed, the time and point of 
administration of medication. An appropriate environment during exercise is also 
required. Excessive heat leads to intense sweating and dehydration. Another factor 
that should not be underestimated during exercise is the use of proper footwear and 
maintenance of foot cleanness so as to prevent infection [53].
2.7 Weight reduction for T2DM
There is solid proof to help lifestyle alterations for those patients with DM who 
are overweight or obese to enhance glycemic control and lessen the requirement 
for medications with T2DM. A few examinations have demonstrated a decrease in 
HbA1c esteems and in addition fasting glucose with low-calorie eats fewer carbohy-
drates in stout patients with T2DM. Overweight and obese people with DM who are 
prepared to accomplish weight reduction ought to have an objective of somewhere 
around 5%weight misfortune through way of life changes [42].
Weight loss is also an important goal because it improves insulin resistance, 
glycemic control, blood pressure, and lipid profiles. Modest weight loss is defined as 
a sustained reduction of 5% of initial body weight and has been shown to improve 
glycemic control & reduce the need for glucose-lowering medications. 5% loss 
shows benefits but sustained loss of > 7% is optimal. A structured lifestyle plan 
that combines dietary modification, activity, and behavioral modification, along 
with ongoing support, is necessary for weight reduction. Lifestyle programs: reduce 
calories by 500-750/day or provide: For women 1.200-1.500 calories/day, adjusted 
for baseline weight. For men 1,500-1.800 calories/day adjusted for baseline weight. 
A reduction in the total calorie intake should allow gradual but systematic body 
weight reduction (by about 0.5–1 kg/week). The diet choice should be based on 
health status & preferences [8].
2.8 Diabetes self-management education and support for T2DM
Self-management is defined as a set of skilled behaviors engaged in to man-
age one’s own illness. This emphasizes the responsibility and role of the diabetic 
patients in managing the disease. Self-management of DM can be achieved by 
self-management education. As part of this education, people with diabetes should 
receive instruction on how and when to perform self-monitoring; how to record the 
results in an organized fashion; the meaning of various blood glucose (BG) levels 
and how behavior and actions affect BG results [38].
Self-management education (SME) is the process of providing the person with 
diabetes the knowledge and skills needed to perform self-care, manage crisis and 
make lifestyle changes required to manage the disease. The goal of the process is to 
enable the patient to become the most knowledgeable and hopefully the most active 
participant in his or her diabetes care. It provides the information regarding vari-
ous treatment options and the benefits and costs of each of these strategies, how to 
make changes in their behaviors and to solve problems [54]. Several meta-analyses 
have demonstrated that SME is associated with clinically important benefits in 
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people with diabetes, such as reductions in glycated hemoglobin and improvements 
in cardiovascular risk factors and reductions in foot ulcerations, infections, and 
amputations [55].
People with diabetes should know how to prevent potential foot problems, 
recognize early presentation without losing time before referral to doctors. Some 
tips for preventing problems such as inspecting feet daily and washing for changes 
in color, texture, odor and firm or hardened areas which may indicate infection and 
potential ulcers. When washing the feet, the water should be warm (not hot), feet 
and areas between toes should be thoroughly dried afterward, applying moistur-
izers, but not between the toes, trimming toenails short and file the edges to avoid 
cutting adjacent toes and Well-fitting footwear is very important. Be sure the shoe is 
wide enough [56].
Self-management support (SMS) includes activities that support the imple-
mentation and maintenance of behaviors for ongoing diabetes self-management, 
including education, behavior modification, and psychosocial and/or clinical 
support. The objective of SME and SMS is to cultivate open doors for individuals 
with diabetes to end up educated and inspired to take part in viable diabetes self-
administration practices and practices ceaselessly. To date, a developing assemblage 
of research proof shows that the blend of both SME and SMS is most profitable for 
enhancing glycemic control, self-viability, self-care practices (i.e., observing of 
blood glucose and good dieting) and decreasing diabetes distress and foot compli-
cations [55].
3. Conceptual framework
Health promotion theories and models can encourage building up, keeping up, 
and enhancing solid practices by anticipating factors affecting unsafe practices. The 
theoretical framework for this study is Pender’s health Promotion model (HPM). 
This model is ideally suited to this study since health-promoting behaviors, espe-
cially when coordinated into a healthy lifestyle, result improved health, enhanced 
functional ability, and better quality of life. Healthy lifestyle behaviors are: health 
responsibility (one’s paying attention to and accepting responsibility for one’s own 
health, being educated about health, and seeking professional assistance when 
necessary), physical activity, nutrition, spiritual growth (one’s sense of self-actual-
ization and purpose), interpersonal relations (one’s ability to develop intimacy and 
closeness), and stress management One’s ability to identify and mobilize psycho-
logical and physical resources to control (including sleep) or reduce anxiety [57].
Pender et al. [58] believed that, health behavior might be persuaded by a desire 
to protect one’s health by avoiding illness or a desire to increase one’s level of health 
in either the presence or absence of illness. Understanding the mechanisms or the 
mediators for behavior change and sustainability of these changes is necessary to 
develop effective health promotion and prevention interventions. Health promo-
tion is the art and science of enabling people to move toward a state of optimal 
health through lifestyle change and is considered a combination of educational 
and ecological supports for actions and conditions of living conducive to health. A 
combination of health promotion strategies is needed to address the multiple deter-
minants of health. Ecological strategies address the social, economic, and physical 
environments that influence health.
Health promotion has moved from being viewed as an objective or wanted end-
point to a process or tool to facilitate movement toward accomplishment of goals. 
It balances individual health behavior choices with creating environments where 
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healthier choices become easier choices. The nurse’s role is to advance a positive 
atmosphere for change, fill in as an impetus for change, assist with various steps of 
the change process, and increase the individual’s capacity to maintain change [59].
3.1 Pender’s health promotion model (HPM)
Pender et al. [60] proposed a framework for coordinating nursing and behav-
ioral science points of view with elements affecting health behaviors. This model 
offered a guide to investigate the complex biopsychosocial processes that motivate 
individuals to take part in practices coordinated toward improving health. This 
model aimed to help nursing professionals comprehend the major determinants 
of health behaviors as a reason for behavioral counseling to advance sound ways 
of life. The HPM integrated constructs from expectancy-value theory and social 
cognitive theory, within a nursing perspective of holistic human functioning. The 
expectancy-value theory is based on the idea that the course of action will likely 
lead to the desired outcome, and that this outcome will be of positive personal 
value. The social cognitive theory describes the concept of perceived self-efficacy 
which is a judgment of one’s ability to carry out a particular course of action. The 
domains of this model include (a) individual characteristics and experiences (previ-
ous behaviors and personal factors); (b) behavior specific cognitions and affects 
(perception of benefits, barriers, self-efficacy, activity related affect, interpersonal 
influences, and situational influences); and (c) behavioral outcomes (commitment 
to the plan of action, and demands and preferences).
The first zone, as found in (Figure 1) is individual characteristics and experi-
ences, which consists of two aspects that affect the willingness to take health 
actions. The first aspect is prior related behavior that is related to the health 
practices and behaviors in the past that influence the existing behavior. The second 
aspect: personal factors that are related to the biological, psychological, and socio-
cultural of the individual. These factors affect the individual’s behavior. Examples 
such as age, gender, body mass index comprises biological factors. Psychological 
factor variables such as; self- esteem, motivation, personal competence, and 
perceived health status are also represented along with race, ethnicity, education 
and socioeconomic status [61].
The second zone, behavior-specific cognitions and affect consist of six other 
aspects: perceived benefits of action, perceived barriers to action, perceived 
Figure 1. 
Diagram of Pender’s health promotion model. Source: [61].
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self-efficacy, activity-related affect, interpersonal influences, and situational influ-
ences. Perceived benefits are perceptions of the positive or reinforcing benefits of 
practicing healthy behaviors. Perceived barriers to action suggest that hindrances 
or obstacles may occur on the process of undertaking healthy behavior. Perceived 
self-efficacy is the personal capability and self-confidence of performing the health 
behavior successfully and believing that change is possible. Being self-efficient 
decreases the perception of barriers to achieving a positive outcome [61].
Activity- related affect is defined as the person’s subjective feeling states or 
emotions before, during and after associated to a specific behavior. A person with 
positive subjective feeling tends to be self-efficient leading to a positive effect. 
Interpersonal influences are behaviors, beliefs and attitudes of family, peers, and 
relevant others in relation to norms, social support and modeling greatly influence 
undertaking such health behaviors. Lastly, situational influences include options 
available, demand characteristics and aesthetic features of the behavior environ-
ment that influence the action [61].
The third zone, behavioral outcome, has three aspects: immediate competing 
demands and preferences, commitment to a plan of action and health promoting 
behavior. The first aspect, immediate competing demands and preferences are 
behaviors that an individual has low or high control of. Individuals have low control 
with regards to competing demands such as work and family responsibilities and 
high control on the competing preferences such as selection of food or diet. These 
factors infringe the course of action prior to the planned healthy behavior. Second, 
commitment to a plan of action is the intention to implement health behavior 
including recognition of strategies to achieve a positive outcome. Lastly, health-
promoting behavior is the final, desired, and positive outcome [61].
The HPM recommended that people have one of a kind individual quality and 
encounters that influence resulting subsequent behavior. The set of variables related 
to behavior specific cognitions and affect are highly motivational to the individual. 
Health promoting behavior is the desired outcome although it can be hindered by 
immediate competing demands and preferences [58]. Individual characteristics 
are generally viewed as indirect influencers of health promoting behaviors while 
behavior-specific cognitions and affect are viewed as direct influencers of behavior. 
Personal factors can be altered by intervention; however, they are generally viewed 
as fixed factors of HPBs. Behavior-specific cognition variables of the HPM, such as 
perceived benefits and barriers, are considered to have major motivational signifi-
cance because they can be altered by nurse intervention [62].
This study concentrated on individual characteristics which are subdivided 
into prior related behavior and personal factors– demographic, socio-economic, 
clinical variables and type 2 diabetic patients’ knowledge regarding diabetes are 
considered to be a personal factor; Regarding to the behavior specific cognitions of 
perceived benefits, the awareness of the lifestyle modification and its positive effect 
on glycemic control are believed to influence the need to undertake a health behav-
ior, Perceived self-efficacy, social support, and situational influences.; and the 
behavioral outcomes of health responsibility, physical activity, nutrition, spiritual 
growth, interpersonal relations, and stress management.
3.2 The role of family and community health nursing
The community health nurses play a pivotal role in the detection, monitoring, 
treatment and prevention of diseases and in health promotion in the whole com-
munity. They help patients to learn or relearn lifestyle practices, as concentrating on 
the patient’s reaction to health and illnesses rather than on the disease itself [63, 64]. 
The focus of community health nursing includes not only the individual, but 
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also the family and the community, meeting these multiple needs requires multiple 
roles. The seven major roles of a community health nurse are: Care provider, educa-
tor, advocate, manager, collaborator, leader and researcher.
The community health nurse as a care provider assists the patient in implement-
ing nursing care plan for disease management. The patient should take an active 
role in disease management, it is the responsibility of the community health nurse 
to promote this self-management and to instill the confidence in the patient that 
they can manage their disease process to remain healthy and decrease the risk of 
potentially deadly complications [17].
During the treatment process, they follow the progress of the patient and 
act accordingly with the patient’s best interests in mind and therefore leading to 
improve diabetes coping skills of those patients. They help their patients adjust 
treatment regimens to ease the burden of diabetes management and to maintain 
good glycemic control and good health. They are responsible for the holistic care 
of patients, which includes a wide range of approaches, including medication, 
education, communication, self-help, and complementary treatment. Holistic care 
increases self-awareness and self-confidence in patients and causes nurses to better 
understand the effects of an illness on a person’s entire life and his/her true needs. 
It also improves harmony between mind, body, emotions and spirit in an ever-
changing environment [65, 66].
The community health nurse ought to guarantee that the patient is on a strict 
dietary regimen and that they are checking blood glucose levels regularly. The nurse 
should also ensure that the patient is complying with medication regimen, checking 
their feet and getting standard eye examinations, not smoking, and practicing rou-
tinely. The community health nurse should monitor the patient’s health status and 
motivate them to be compliant with the prescribed treatment regimen. The nurse 
should encourage and motivate the patient to take active role in avoiding further 
complications and to remain compliant with the prescribed treatment regimen and 
follow up arrangements [17].
The community health nurse as an educator provides health teaching and 
education through health promotion programs and services. Diabetic health teach-
ing in regard to health promotion and prevention is an ideal role of them because 
of the overwhelming rate of diabetes and knowledge deficit of the individuals. 
Concerning diabetes, an individual must be committed to self-health promoting 
behaviors and to adopting a lifestyle change or else non-compliance will result and 
complications of the disease process could follow [17].
The community health nurse educates about health and wellness activities 
such as healthy diet, regular exercise, smoking cessation. The patient should be 
encouraged and expected to take active role in creating and maintain healthy 
behaviors. Concerning individualized characteristics and experiences, the patient 
must examine his or her own behaviors including diet, and level of physical activ-
ity, body fat and weight, and settle on a decision to change unhealthy behaviors to 
health promoting behaviors. The patient will be instructed to be proactive in their 
own health. The patient will be made to understand that maintain a healthy lifestyle 
will decrease the chances of getting diabetes. Personal responsibility is the key to 
diabetes prevention and treatment [17].
The community health nurse assists the patient in early recognition of the 
signs and symptoms of diabetes and to take control of the disease before potential 
complications emerge. For those who are prediabetic, it is imperative for com-
munity health nurse to clarify the signs and symptoms of hyperglycemia besides 
what to report to the physician. It is critical to screen those at risk for diabetes. The 
early diagnosis is similarly as vital. If diabetes is caught prior to the point where 
complications arise then it will be easier for the patient to be proactive in health 
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promotion. Besides, as blood glucose levels are controlled, the risk of complications 
diminishes. During educational treatment they are responsible for ensuring that 
patients are able to understand their health, illnesses, medications, and treatments 
to the best of their ability. It is fundamental to assess whether the individual with 
diabetes or a close relative has comprehended the messages and has adequate  
self-care abilities or skills [17].
The community health nurse as advocator advocates for the patients’ rights 
and maintains the patient’s dignity. Every patient has the right to receive, just, 
equal, and human treatment. This is particularly important for patients who are 
the poor, the disadvantaged, those without health insurance because they become 
frustrated, confused, degraded, and unable to cope with the system on their 
own. The community health nurse often acts as an advocate for patients, plead-
ing their cause or acting on their behalf, Clients may need some one: To explain 
which services to expect, which services they ought to receive; to make referrals as 
needed; to write letters to agencies or health care providers for them; and to assure 
the satisfaction of their needs. The advocate role incorporates four characteris-
tics actions: Being assertive; taking risks; communicating & negating well; and 
identifying recourses and obtaining results. The community health nurse support 
the patient and represent the patients best interests at all times, especially when 
treatment decisions are being made [67].
The community health nurse as a manger exercises administrative direction 
toward the accomplishment of specified goals by: Assessing patients’ needs; plan-
ning and organizing to meet those needs; controlling; and evaluating the progress 
to ensure that goals are met. These activities are sequential and yet also occur 
simultaneously for managing service objectives. As other health professionals are 
usually responsible for making the final treatment decisions, nurses should be able 
to communicate information regarding patient health effectively. In this, the com-
munity health nurse facilitates collaboration, coordination, and cooperation among 
caregivers for continuity of care for the patient and promoting the best patient 
health outcomes [67].
The community health nurse as a collaborator enables and promotes the inter-
professional teamwork and comprehensive care provided by healthcare profes-
sionals, paraprofessionals, and volunteers. The collaborator role also may involve 
functioning as a consultant with other healthcare colleagues to inform decision-
making and planning to meet healthcare consumer needs therefore, provide proper 
care and improve patient outcomes. This role requires communication skills, skill in 
interpreting the nurse’s unique contribution to the team and acting assertively as an 
equal partner [67, 68].
The community health nurse as a leader focuses on affecting change, thus the 
nurse becomes an agent of change. The community health nurse seeks to initiate 
changers that positively affect people’s health. They also seek to influence people to 
think and behave differently about their health and the factors contributing to it. 
The care for diabetic patients includes adopting a healthy lifestyle where the diet 
plan represents an important support of care so they can meet their goals. At the 
community level, the leadership role may involve working with a team of profes-
sionals to direct and coordinate such as a campaign to eliminate smoking in public 
areas [67, 69].
The community health nurse as a researcher engages in systematic investigation, 
collection, and analysis of data for solving problems and enhancing community 
health practice. The community health nurse often participates in agency and 
organizational studies to determine such matters as risks associated with home 
visiting. The researcher role helps to determine needs, evaluate effectiveness of 
care, and develop theoretic bases for community health nursing practice. Nurses 
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must become responsible users of research, keeping up-to-date of new knowledge 
and applying it in practice. Nurses must learn to evaluate nursing research articles 
critically, assessing their validity and applicability to their own practice. A commit-
ment to use and conduct of research will move the nursing profession forward and 
enhance its influence on the health of at-risk populations [67].
The main results of the present study could be outlined in the following points:
Results revealed that 68.5% of the studied sample groups were females and 
64.1% of them aged from 45-64 years with mean 49.76 ± 9.19 years.
Regarding educational level, 42.4% of the studied sample groups were illiterate. 
Whereas, 63.0% were unemployed, 68.5% of them came from urban areas, and 
76.2% of them had low social class level.
Regarding diabetes history, 43.5% of the studied sample had rare attacks, 96.7% 
of them have taken oral hypoglycemic agents, 94.6% of them were not following 
planned diet regimen and 76.1% of them did not do physical activities.
Independent t-test demonstrated high significant difference (P-value < 0.005) 
between pre-test study and control groups’ total score of knowledge & knowledge 
related practice about DM. Though, this result was of unnecessary inconsistency 
between the two groups, both levels of their pre-test knowledge and practices about 
diabetes mellitus were still inadequate. Independent t-test demonstrated also that 
there was only statistical significant difference (P-value < 0.023) between the two 
groups regarding pre-test health responsibility domain. It can be concluded from 
outputs that the mean scores between control and study were successful in achiev-
ing homogeneity of most sub-class groups.
However, differences regarding clinical data between pre-test study and con-
trol groups were statistically insignificant. Generally, the mean scores of groups 
between control and study were homogeneous for all sub-class groups.
Results of Paired t-test between total score of knowledge & knowledge related 
practice about DM, health promoting lifestyle domains values and clinical data, 
before and after the program intervention in the study group revealed high sig-
nificant differences represented in (P-value < 0.009 or P-value < 0.001 or P-value 
< 0.0001). Patients who received lifestyle modification intervention program 
achieved better total score of knowledge & knowledge related practice about DM, 
health promoting lifestyle domains values and clinical data.
Statistical results of Paired t-test that was computed between total score of 
knowledge & knowledge related practice about DM pre- and post-tests in the con-
trol group, have illustrated high significant differences (P-value < 0.0001). Those 
patients were still having inadequate and insufficient total score of knowledge & 
knowledge related practice about DM.
Statistical results of Paired t-test that were computed between health promot-
ing lifestyle domains pre- and post-tests pre- and post-tests in the control group, 
have illustrated statistical significant differences of all domains except that for 
the physical activity and interpersonal relations domains. Patients though didn’t 
receive a lifestyle modification intervention, have had slight increases (with no 
trend change) in their total scores of overall health promoting lifestyle score, health 
responsibility, nutrition, spiritual growth, stress management domains.
Statistical results of Paired t-test that were computed between clinical data 
pre- and post-tests in the control group have not revealed any statistical significance 
regarding clinical data.
Glycated Hemoglobin multiple linear regressions demonstrated a statistical 
significant positive independent predictor (fasting plasma glucose; P-value < 
0.0001), whereas the Physical Activity Domain was the only statistical significant 
negative independent predictor (P-value < 0.015) after employing the program in 
the study group.
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4. Conclusions
Based on the findings of the current study, it could be concluded that: Type 2 
diabetic patients who have received lifestyle modification program (dietary modi-
fication, physical activity, self-blood glucose monitoring and diabetes self-care 
education) and attended to the Family Medicine Outpatient Clinic & the Diabetic 
Outpatient Clinic of Suez Canal University Hospitals at Ismailia city in Egypt has 
a positive effect on glycemic control (HbA1c) among patients with type 2 diabetes 
mellitus and also improved their knowledge and practices about DM post lifestyle 
modification program.
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